About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Organoids can Help Personalize Therapy for Gastrointestinal Cancers

by Hannah Joy on January 22, 2018 at 6:54 PM
Font : A-A+

Organoids can Help Personalize Therapy for Gastrointestinal Cancers

The 3D organoid models derived from patient cells aid in developing personalized therapy for each and every individual suffering with gastrointestinal cancer.

Organoids are artificially grown masses of cells or tissues that resemble organs that are being used by researchers in a range of biomedical fields as they study various disease states and work to develop potential treatments.

Advertisement


Organoid culture methods have been established for healthy and diseased tissues from oesophagus, stomach, intestine, pancreas, bile duct, and liver.

Because organoids can be generated with high efficiency and speed from patient samples, they can serve as a personal cancer model that can guide clinical decision-making.
Advertisement

"Research using organoids has already unraveled so many of the underlying causes of cancer. But, for me, their real promise lies in their capacity to predict treatment response," said lead author Merel Aberle, MD, of Maastricht University, in The Netherlands.

"In future, organoids could be used to find the best treatment combination for every patient, thereby increasing response rates, but also reducing the side-effects unnecessary treatment may cause. I hope that this review inspires more surgeons, oncologists, radiologists, and other healthcare professionals to use this model and set up collaborative clinical trials."

The new study was published in British Journal of Surgery (BJS).



Source: Eurekalert
Advertisement

Advertisement
Advertisement

Latest Cancer News

How Do Neutrophils Impact Pancreatic Cancer Treatment Resistance?
A nanoengineering platform targets neutrophils, the white blood cells without killing pancreatic cancer cells paving the way for effective treatments.
Lung Cancer: The Survival Advantage of Lobectomy Over Wedge Resection
The survival rates between lobectomy and wedge resection surgical procedures were found to be the same among lung cancer patients.
Could TKI Cancer Drugs Lead to Inflammatory Side Effects?
The mechanism by which the kinases cause inflammation has been discovered by scientists.
Are Biomarkers the Key to Identifying Early Pancreatic Risk?
Pancreatic cancer cases are on the rise. The biomarker approach could reduce the chance of developing pancreatic cancer.
How Do New Drugs Work Together to Reduce Lung Tumors?
New combination of medications trametinib and entinostat were found to decrease lung cancer in mice.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Organoids can Help Personalize Therapy for Gastrointestinal Cancers Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests